ADMA ADMA Biologics Inc - Common Stock
$9,96
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$7–$20
21% of range
Analystenbewertung
BUY
11 analysts
Kursziel
$17
+71% upside
P/E (TTM)
16.6
ROE
33.6%
Nettogewinnmarge
28.8%
Über ADMA Biologics Inc - Common Stock Unternehmensübersicht von Wikipedia
ADMA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.96
Marktkapitalisierung
$2.37B
P/E (TTM)
16.6
EPS (TTM)
$0.60
Umsatz (TTM)
$510M
Dividendenrendite
—
ROE
33.6%
Verschuldungsgrad
0.2
52W-Spanne
$7 – $20
ADMA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$510M
2023-12-31
→
2025-12-31
EPS
$0.60
2023-12-31
→
2025-12-31
Freier Cashflow
$28M
2023-12-31
→
2025-12-31
Margen
28.8%
2023-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ADMA
Peer-Median
P/E (TTM)
16.6
55.4
P/S (TTM) (K/V (TTM))
4.6
7.7
P/B (K/B)
5.0
7.1
EV / EBITDA
11.8
—
Price / FCF (Kurs / FCF)
85.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ADMA
Peer-Median
Gross Margin (Bruttogewinnmarge)
57.4%
71.7%
Operating Margin (Betriebsgewinnmarge)
37.5%
—
Net Profit Margin (Nettogewinnmarge)
28.8%
-2.0%
ROA
26.4%
-32.7%
ROE
33.6%
-37.9%
ROIC
28.0%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ADMA
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.2
18.7
Current Ratio (Liquiditätsgrad)
6.7
7.4
Quick Ratio
3.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ADMA
Peer-Median
Revenue YoY (Umsatz YoY)
19.6%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
49.0%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
64.6%
—
EPS YoY (EPS VjV)
-25.9%
—
Net Income YoY (Nettogewinn YoY)
-25.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ADMA
Peer-Median
ADMA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
11 Analysten
- Starker Kauf 2 18,2%
- Kauf 7 63,6%
- Halten 2 18,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-17
Median
$17.00
← Unter allen Zielen
$9.96
Tief
$12.00
Hoch
$21.00
Median-Ziel
$17.00
+70,8%
Mittelwert-Ziel
$17.00
+70,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $0.16 | $0.18 | -0.02% |
| 31. März 2026 | $0.19 | $0.20 | -0.01% |
| 31. Dezember 2025 | $0.20 | $0.19 | 0.01% |
| 30. September 2025 | $0.15 | $0.15 | -0.00% |
| 30. Juni 2025 | $0.14 | $0.14 | -0.00% |
| 31. März 2025 | $0.11 | $0.16 | -0.05% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GENB | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Cost of Revenue | $217M | $207M | $169M | $119M | $80M | $61M | $40M | $42M | $29M | $2M | $4M | $4M | |
| Gross Profit | $293M | $220M | $89M | $35M | $1M | $-19M | · | $-25M | $-6M | $4M | $3M | $2M | |
| R&D Expense | $5M | $2M | $3M | $4M | $4M | $6M | $2M | $4M | $6M | $8M | $7M | $10M | |
| SG&A Expense | $92M | $74M | $59M | $52M | $43M | $35M | $26M | $23M | $19M | $8M | $7M | $5M | |
| Operating Expenses | $101M | $81M | $67M | $75M | $60M | $46M | $71M | $77M | $62M | $28M | $23M | $22M | |
| Operating Income | $191M | $139M | $22M | $-39M | $-58M | $-65M | $-41M | $-60M | $-39M | $-17M | $-16M | $-16M | |
| Interest Expense | · | · | $25M | $19M | $13M | $12M | $9M | $6M | $3M | $2M | $2M | $1M | |
| Interest Income | $2M | $2M | $2M | $45.0K | $35.0K | $288.1K | $800.8K | · | · | · | · | · | |
| Other Non-op | $-212.0K | $-193.0K | $-287.0K | $-635.0K | $-252.0K | $-128.5K | $-227.3K | $-127.1K | $-10.1K | $4.5K | $-2M | $-1M | |
| Pretax Income | $183M | $126M | $-28M | $-66M | · | · | · | · | · | $-20M | $-18M | $-17M | |
| Income Tax | $36M | $-72M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-551.7K | |
| Net Income | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| EPS (Basic) | $0.62 | $0.85 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| Shares (Basic) | 238,299,024 | 233,084,236 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| Shares (Diluted) | 244,904,640 | 243,342,466 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| EBITDA | $199M | $147M | $29M | $-33M | $-54M | $-62M | $-39M | $-58M | $-38M | $-17M | $-15M | $-16M |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $103M | $51M | $87M | $51M | $56M | $27M | $27M | $43M | $10M | $10M | $17M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $5M | $6M | $5M | |
| Receivables | $158M | $50M | $27M | $16M | $29M | $13M | $3M | $1M | $4M | $1M | $924.5K | $384.0K | |
| Inventory | $206M | $170M | $173M | $163M | $125M | $82M | $53M | $19M | $13M | $5M | $3M | $2M | |
| Prepaid Expense | $7M | $8M | $5M | $5M | $4M | $3M | $3M | $2M | $1M | $313.9K | $111.0K | $143.6K | |
| Current Assets | $467M | $331M | $257M | $270M | $209M | $154M | $86M | $45M | $62M | $22M | $21M | $24M | |
| PP&E (Net) | $65M | $55M | $54M | $58M | $51M | $42M | $32M | $30M | $30M | $2M | $2M | $3M | |
| PP&E (Gross) | $103M | $88M | $81M | $78M | $64M | $50M | $37M | $34M | $32M | $4M | $4M | $4M | |
| Accum. Depreciation | $38M | $34M | $27M | $19M | $13M | $9M | $6M | $3M | $1M | $2M | $2M | $1M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $0 | · | · | |
| Intangibles | $632.0K | $460.0K | $499.0K | $1M | $2M | $2M | $3M | $4M | $5M | $0 | · | · | |
| Total Assets | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Accounts Payable | $23M | $20M | $16M | $13M | $12M | $11M | $9M | $6M | $6M | $3M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | $8M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $0 | $6M | $0 | · | |
| Current Liabilities | $70M | $56M | $50M | $39M | $30M | $20M | $14M | $10M | $9M | $11M | $4M | $4M | |
| Capital Leases | $7M | $9M | $10M | $11M | $7M | $4M | $1M | $119.1K | $0 | $19.7K | $36.3K | $51.4K | |
| Other Non-current Liabilities | $0 | $360.0K | $419.0K | $350.0K | $397.4K | $54.9K | $106.6K | $260.7K | $106.0K | $117.8K | $1M | $132.5K | |
| Total Liabilities | $147M | $140M | $194M | $196M | $135M | $119M | $101M | $69M | $68M | $28M | $23M | $21M | |
| Long-term Debt | $72M | $72M | · | · | · | · | $0 | $3M | $3M | $2M | · | · | |
| Total Debt | $72M | · | · | · | · | · | · | $0 | $0 | $6M | · | · | |
| Common Stock | $24.0K | $24.0K | $23.0K | $22.0K | $19.6K | $10.5K | $5.9K | $4.6K | $3.7K | $1.3K | $1.1K | $929 | |
| Paid-in Capital | $671M | $658M | $641M | $630M | $553M | $429M | $291M | $236M | $191M | $102M | $88M | $75M | |
| Retained Earnings | $-162M | $-309M | $-506M | $-478M | $-412M | $-340M | $-265M | $-216M | $-151M | $-107M | $-87M | $-69M | |
| Treasury Stock | $32M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $477M | $349M | $135M | $152M | $141M | $88M | $26M | $20M | $40M | $-4M | $821.0K | $6M | |
| Liabilities + Equity | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Shares Outstanding | 237,874,496 | 236,620,545 | 226,063,032 | 221,816,930 | 195,813,817 | 104,902,888 | 59,318,355 | 46,353,068 | 36,725,499 | 12,886,741 | 10,713,087 | 9,291,823 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $6M | $5M | $3M | $2M | $3M | $2M | $400.0K | $469.8K | $247.9K | |
| Stock-based Comp | $20M | $14M | $6M | $5M | $3M | $3M | $3M | $2M | $2M | $1M | $2M | $1M | |
| Deferred Tax | $11M | $-84M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $144.0K | $388.0K | $724.0K | $715.0K | $715.0K | $715.4K | $844.9K | $844.9K | $1M | $0 | · | · | |
| Other Non-cash | $-136M | $-16M | $23M | $-5M | $-49M | $-32M | $-33M | $-2M | $3M | $-473.5K | $370.7K | $611.9K | |
| Operating Cash Flow | $50M | $119M | $9M | $-60M | $-112M | $-102M | $-76M | $-63M | $-37M | $-18M | $-15M | $-15M | |
| CapEx | $23M | $8M | $5M | $14M | $14M | $13M | $4M | $2M | $3M | $73.4K | $26.1K | $2M | |
| Investing Cash Flow | $-22M | $-9M | $-5M | $-14M | $-14M | $-13M | $-4M | $-2M | $15M | $904.6K | $-2M | $-4M | |
| Debt Issued | · | · | · | · | · | $28M | $72M | $0 | $30M | $4M | · | · | |
| Net Debt Issued | · | · | · | · | · | $14M | $72M | $0 | $30M | · | · | · | |
| Stock Issued | · | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $13M | $10M | $0 | |
| Stock Repurchased | $32M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-32M | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $14M | $10M | $0 | |
| Financing Cash Flow | $-44M | $-58M | $-39M | $109M | $121M | $144M | $80M | $43M | $61M | $17M | $10M | $10M | |
| Net Change in Cash | $-16M | $52M | $-35M | $35M | $-5M | $29M | $-2.7K | $-22M | $39M | $-526.1K | $-7M | $-9M | |
| Taxes Paid | $20M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $28M | $110M | $4M | $-73M | $-126M | $-115M | $-80M | $-65M | $-40M | $-18M | $-15M | $-17M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-21M | $-17M | $-18M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.4% | 51.5% | 34.4% | 22.9% | 1.5% | · | · | -148.4% | -28.1% | 40.3% | 39.9% | 36.7% | |
| Operating Margin | 37.5% | 32.6% | 8.4% | -25.6% | -72.1% | -153.8% | -141.1% | -354.9% | -172.7% | -162.6% | -216.1% | -270.8% | |
| Net Margin | 28.8% | 46.4% | -10.9% | -42.8% | -88.5% | -179.4% | -164.5% | -387.1% | -192.3% | -183.1% | -250.4% | -284.2% | |
| Pretax Margin | 35.8% | 29.5% | · | · | · | · | · | · | · | -183.1% | -250.4% | -293.6% | |
| EBITDA Margin | 39.1% | 34.4% | 11.3% | -21.4% | -66.2% | -146.2% | -133.0% | -339.6% | -166.1% | -158.1% | -209.6% | -266.6% | |
| ROA | 26.4% | 45.0% | -8.3% | -20.3% | -27.8% | -38.1% | -47.0% | -67.3% | -66.5% | -82.3% | -70.8% | -56.8% | |
| ROE | 33.6% | 68.1% | -19.7% | -52.2% | -58.7% | -94.9% | -155.0% | -230.8% | -243.9% | 1073.4% | -526.2% | -153.5% | |
| ROIC | 28.0% | 62.6% | · | · | · | · | · | · | · | -1047.9% | -1889.7% | -258.1% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 6.0 | 5.2 | 6.9 | 6.9 | 7.7 | 6.1 | 4.6 | 6.7 | 1.9 | 5.0 | 5.7 | |
| Quick Ratio | 3.5 | 2.8 | 1.6 | 2.6 | 2.6 | 3.5 | 2.2 | 2.5 | 5.0 | 1.5 | 4.2 | 5.3 | |
| Debt / Equity | 0.2 | · | · | · | · | · | · | 0.0 | 0.0 | -1.4 | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 0.9 | -2.0 | -4.5 | -5.4 | -4.6 | -10.9 | -12.0 | -7.7 | -8.4 | -12.5 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.0 | 0.8 | 0.5 | 0.3 | 0.2 | 0.3 | 0.2 | 0.3 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.2 | 1.2 | 1.0 | 0.8 | 0.8 | 0.9 | 1.1 | 2.7 | 0.3 | 1.5 | 1.7 | 2.8 | |
| Receivables Turnover | 4.9 | 11.0 | 12.0 | 7.0 | 3.9 | 5.1 | 12.1 | 6.4 | 9.3 | 11.0 | 11.0 | 13.6 |
Wachstumsraten 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.6% | 65.1% | 67.6% | 90.4% | 91.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 49.0% | 74.0% | 82.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 64.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -25.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -25.7% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Net Income TTM | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| Market Cap | $4.34B | $4.06B | $1.02B | $861M | $276M | $205M | $237M | $111M | $118M | $66M | $86M | $104M | |
| Enterprise Value | $4.32B | · | · | · | · | · | · | $88M | $75M | $57M | · | · | |
| P/E | 30.4 | 21.2 | -34.8 | -11.8 | -2.8 | -2.2 | · | · | · | · | · | · | |
| P/S | 8.5 | 9.5 | 4.0 | 5.6 | 3.4 | 4.8 | 8.1 | 6.5 | 5.2 | 6.2 | 12.0 | 17.5 | |
| P/B | 9.1 | 11.6 | 7.6 | 5.7 | 2.0 | 2.3 | 9.1 | 5.6 | 2.9 | -14.8 | 105.3 | 17.3 | |
| P / Tangible Book | 9.2 | 11.8 | 7.8 | 5.8 | 2.0 | 2.5 | · | · | · | · | · | · | |
| P / Cash Flow | 86.1 | 34.2 | 116.1 | -14.5 | -2.5 | -2.0 | -3.1 | -1.8 | -3.2 | -3.6 | -5.6 | -7.1 | |
| P / FCF | 156.0 | 36.7 | 253.6 | -11.7 | -2.2 | -1.8 | -3.0 | -1.7 | -3.0 | -3.6 | -5.6 | -6.1 | |
| EV / EBITDA | 21.7 | · | · | · | · | · | · | -1.5 | -2.0 | -3.4 | · | · | |
| EV / FCF | 155.4 | · | · | · | · | · | · | -1.4 | -1.9 | -3.1 | · | · | |
| EV / Revenue | 8.5 | · | · | · | · | · | · | 5.2 | 3.3 | 5.3 | · | · | |
| Earnings Yield | 3.3% | 4.7% | -2.9% | -8.5% | -36.2% | -45.1% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124M | $114M | $139M | $134M | $122M | $115M | $118M | $120M | $107M | $82M | $74M | $67M | $60M | $57M | $50M | $41M | |
| Cost of Revenue | $38M | $34M | $50M | $59M | $55M | $54M | $54M | $60M | $50M | $43M | $43M | $43M | $43M | $40M | $36M | $31M | |
| Gross Profit | $86M | $81M | $89M | $76M | $67M | $61M | $63M | $60M | $57M | $39M | $31M | $25M | $17M | $17M | $14M | $10M | |
| R&D Expense | $6M | $3M | $1M | $2M | $1M | $826.0K | $391.0K | $412.0K | $560.0K | $450.0K | $446.0K | $596.0K | $1M | $855.0K | $1M | $1M | |
| SG&A Expense | $27M | $27M | $24M | $22M | $22M | $24M | $23M | $19M | $17M | $16M | $16M | $15M | $14M | $15M | $14M | $13M | |
| Operating Expenses | $34M | $22M | $26M | $25M | $24M | $26M | $25M | $20M | $18M | $17M | $17M | $16M | $17M | $17M | $20M | $19M | |
| Operating Income | $52M | $58M | $63M | $51M | $43M | $35M | $38M | $40M | $39M | $22M | $14M | $9M | $-473.0K | $-813.0K | $-6M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $6M | $6M | $6M | · | $6M | |
| Interest Income | · | · | $487.0K | $376.0K | $400.0K | $608.0K | $598.0K | $666.0K | $449.0K | $384.0K | $614.0K | $423.0K | $414.0K | $166.0K | $2.4K | $7.2K | |
| Other Non-op | $-22.0K | $-140.0K | $-19.0K | $-21.0K | $-108.0K | $-64.0K | $-86.0K | $-56.0K | $-16.0K | $-35.0K | $-102.0K | $-145.0K | $-13.0K | $-27.0K | $-439.1K | $-9.6K | |
| Pretax Income | $50M | $57M | $62M | $48M | $40M | $33M | $35M | $37M | $36M | $18M | $-18M | $3M | $-6M | $-7M | · | · | |
| Income Tax | $12M | $12M | $12M | $11M | $6M | $7M | $-77M | $840.0K | $4M | $595.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $38M | $45M | $49M | $36M | $34M | $27M | $112M | $36M | $32M | $18M | $-18M | $3M | $-6M | $-7M | $-12M | $-15M | |
| EPS (Basic) | $0.17 | $0.19 | $0.22 | $0.15 | $0.14 | $0.11 | $0.48 | $0.15 | $0.14 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| EPS (Diluted) | $0.16 | $0.19 | $0.20 | $0.15 | $0.14 | $0.11 | $0.45 | $0.15 | $0.13 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| Shares (Basic) | 228,232,503 | 236,072,751 | -479,570,145 | 238,602,978 | 241,490,715 | 237,775,476 | -462,779,632 | 234,571,376 | 232,417,645 | 228,874,847 | -445,904,808 | 225,276,980 | 222,683,393 | 221,921,750 | -390,734,157 | 196,383,935 | |
| Shares (Diluted) | 230,337,048 | 239,955,762 | -493,044,433 | 244,664,263 | 248,608,460 | 244,676,350 | -480,043,045 | 244,804,065 | 242,167,072 | 236,414,374 | -454,389,090 | 233,761,262 | 222,683,393 | 221,921,750 | -390,734,157 | 196,383,935 | |
| EBITDA | $54M | $60M | · | $53M | $45M | $37M | · | $42M | $41M | $24M | · | $11M | $1M | $1M | · | $-8M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $138M | $88M | $61M | $90M | $72M | $103M | $87M | $88M | $45M | · | $74M | $63M | $69M | · | $35M | |
| Receivables | $138M | $136M | $158M | $138M | $110M | $99M | $50M | $50M | $30M | $50M | · | $31M | $37M | $27M | · | $21M | |
| Inventory | $239M | $222M | $206M | $197M | $191M | $172M | $170M | $172M | $180M | $178M | · | $163M | $162M | $164M | · | $163M | |
| Prepaid Expense | $15M | $15M | $7M | $7M | $8M | $9M | $8M | $10M | $6M | $4M | · | $5M | $5M | $4M | · | $5M | |
| Current Assets | $528M | $511M | $467M | $403M | $400M | $352M | $331M | $318M | $304M | $276M | · | $274M | $266M | $264M | · | $224M | |
| PP&E (Net) | $67M | $65M | $65M | $70M | $58M | $58M | $55M | $54M | $54M | $55M | · | $55M | $56M | $57M | · | $57M | |
| PP&E (Gross) | $108M | $105M | $103M | · | $95M | $93M | $88M | $86M | $85M | $84M | · | $80M | $80M | $79M | · | $75M | |
| Accum. Depreciation | $42M | $40M | $38M | · | $38M | $35M | $34M | $32M | $31M | $29M | · | $25M | $23M | $21M | · | $18M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Intangibles | $575.0K | $630.0K | $632.0K | $491.0K | $527.0K | $452.0K | $460.0K | $485.0K | $479.0K | $321.0K | · | $476.9K | $655.7K | $834.6K | · | $1M | |
| Total Assets | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | $329M | $349M | $343M | $341M | $348M | $301M | |
| Accounts Payable | $32M | $21M | $23M | $24M | $30M | $21M | $20M | $16M | $14M | $17M | · | $11M | $12M | $13M | · | $25M | |
| Current Liabilities | $76M | $74M | $70M | $56M | $75M | $53M | $56M | $45M | $44M | $53M | · | $42M | $42M | $37M | · | $44M | |
| Capital Leases | $6M | $6M | $7M | $9M | $9M | $8M | $9M | $9M | $9M | $9M | · | $10M | $10M | $10M | · | $11M | |
| Other Non-current Liabilities | · | · | $0 | $90.0K | $2.0K | $2.0K | $360.0K | $375.0K | $390.0K | $405.0K | · | $434.6K | $449.5K | $338.7K | · | $362.2K | |
| Total Liabilities | $276M | $275M | $147M | $138M | $160M | $137M | $140M | $159M | $188M | $197M | · | $198M | $196M | $195M | · | $200M | |
| Long-term Debt | $197M | $197M | $72M | $72M | · | · | $72M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $197M | $197M | · | $72M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $23.0K | $23.0K | · | $22.6K | $22.5K | $22.2K | · | $19.7K | |
| Paid-in Capital | $675M | $650M | $671M | $665M | $661M | $655M | $658M | $652M | $645M | $642M | · | $640M | $638M | $630M | · | $566M | |
| Retained Earnings | $-79M | $-116M | $-162M | $-211M | $-247M | $-282M | $-309M | $-420M | $-456M | $-488M | · | $-489M | $-491M | $-485M | · | $-466M | |
| Treasury Stock | $188M | $143M | $32M | $23M | $15M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $408M | $390M | $477M | $431M | $398M | $373M | $349M | $232M | $188M | $154M | $135M | $151M | $147M | $146M | $152M | $100M | |
| Liabilities + Equity | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | · | $349M | $343M | $341M | · | $301M | |
| Shares Outstanding | 225,355,228 | 232,288,977 | 237,874,496 | 238,332,393 | 238,567,308 | 238,532,252 | 236,620,545 | 236,378,607 | 233,026,736 | 231,769,765 | · | 225,958,084 | 224,526,748 | 222,262,588 | · | 196,776,871 |
Cashflow 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Deferred Tax | $3.0K | $3M | $1M | $5M | $2M | $3M | $-84M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | $55.0K | $55.0K | $49.0K | $38.0K | $32.0K | $25.0K | $25.0K | $28.0K | $142.0K | $193.0K | $187.0K | $179.0K | $179.0K | $179.0K | $178.5K | $178.8K | |
| Other Non-cash | · | $2M | · | · | · | $-57M | · | · | · | $-24M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $30M | $58M | $36M | $13M | $21M | $-20M | $50M | $25M | $46M | $-2M | $18M | $12M | $-6M | $-15M | $-7M | $-13M | |
| CapEx | $2M | $3M | $1M | $14M | $2M | $5M | $3M | $1M | $2M | $2M | $1M | $756.8K | $872.4K | $2M | $4M | $3M | |
| Investing Cash Flow | $-2M | $2M | $-276.0K | $-14M | $-3M | $-5M | $-3M | $-1M | $-2M | $-2M | $-1M | $-756.8K | $-872.4K | $-2M | $-4M | $-3M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $65M | $0 | |
| Stock Repurchased | $25M | $130M | $9M | $23M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-130M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-29M | $-10M | $-9M | $-28M | $48.0K | $-7M | $-31M | $-25M | $-362.0K | $-1M | $-39M | $416.4K | $240.5K | $-650.0K | $63M | $-843.8K | |
| Net Change in Cash | $-2M | $51M | $26M | $-29M | $19M | $-32M | $16M | $-2M | $43M | $-6M | $-23M | $12M | $-7M | $-17M | $52M | $-18M | |
| Free Cash Flow | · | $56M | · | · | · | $-24M | · | · | · | $-5M | · | · | · | $-17M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | · | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 70.5% | · | 56.3% | 55.1% | 53.2% | · | 49.8% | 53.6% | 47.8% | · | 36.6% | 27.8% | 29.0% | · | 23.5% | |
| Operating Margin | 42.2% | 50.9% | · | 38.0% | 35.1% | 30.4% | · | 33.1% | 36.6% | 26.7% | · | 12.9% | -0.79% | -1.4% | · | -22.7% | |
| Net Margin | 30.4% | 39.6% | · | 27.1% | 28.1% | 23.4% | · | 30.0% | 29.9% | 21.8% | · | 3.8% | -10.6% | -11.9% | · | -36.3% | |
| Pretax Margin | 40.4% | 49.9% | · | 35.4% | 32.9% | 29.1% | · | 30.7% | 33.5% | 22.5% | · | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 52.5% | · | 39.5% | 36.7% | 32.0% | · | 34.7% | 38.3% | 29.0% | · | 15.7% | 2.4% | 1.9% | · | -18.5% | |
| ROA | 6.1% | 7.7% | · | 7.6% | 7.3% | 6.2% | · | 9.7% | 8.9% | 5.1% | · | 0.79% | -2.0% | -2.1% | · | -5.5% | |
| ROE | 9.4% | 11.9% | · | 11.0% | 11.7% | 10.2% | · | 18.7% | 19.1% | 11.9% | · | 2.0% | -4.9% | -5.0% | · | -14.7% | |
| ROIC | 6.5% | 7.9% | · | 7.8% | 9.2% | 7.5% | · | 16.7% | 18.6% | 13.7% | · | · | · | · | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 7.0 | · | 7.1 | 5.3 | 6.6 | · | 7.1 | 6.9 | 5.2 | · | 6.5 | 6.3 | 7.2 | · | 5.0 | |
| Quick Ratio | 3.6 | 3.7 | · | 3.5 | 2.7 | 3.2 | · | 3.0 | 2.7 | 1.8 | · | 2.5 | 2.4 | 2.6 | · | 1.3 | |
| Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.8 | · | 1.4 | -0.1 | -0.1 | · | -1.7 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.4 | 1.7 | 1.5 | · | 2.9 | 3.2 | 2.2 | · | 2.6 | 2.2 | 2.2 | · | 2.0 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $495M | $486M | · | $491M | $464M | $424M | · | $376M | $316M | $266M | · | $225M | $192M | $161M | · | $125M | |
| Net Income TTM | $154M | $143M | · | $133M | $129M | $113M | · | $88M | $46M | $7M | · | $-25M | $-42M | $-60M | · | $-71M | |
| Market Cap | $1.89B | $2.09B | · | $3.49B | $4.34B | $4.73B | · | $4.73B | $2.61B | $1.53B | · | $809M | $829M | $736M | · | $478M | |
| Enterprise Value | $1.95B | $2.15B | · | $3.50B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 13.1 | 15.3 | · | 26.7 | 34.4 | 42.2 | · | 54.0 | 58.8 | 220.0 | · | -27.5 | -17.6 | -10.7 | · | -5.9 | |
| P/S | 3.8 | 4.3 | · | 7.1 | 9.4 | 11.2 | · | 12.6 | 8.2 | 5.7 | · | 3.6 | 4.3 | 4.6 | · | 3.8 | |
| P/B | 4.6 | 5.4 | · | 8.1 | 10.9 | 12.7 | · | 20.4 | 13.8 | 10.0 | · | 5.3 | 5.6 | 5.1 | · | 4.8 | |
| P / Tangible Book | 4.7 | 5.4 | · | 8.2 | 11.0 | 12.8 | · | 20.7 | 14.1 | 10.2 | · | 5.5 | 5.8 | 5.2 | · | 5.0 | |
| P / Cash Flow | · | 35.9 | · | · | · | -240.5 | · | · | · | -689.7 | · | · | · | -50.0 | · | · | |
| P / FCF | · | 37.6 | · | · | · | -194.1 | · | · | · | -335.1 | · | · | · | -44.1 | · | · | |
| EV / EBITDA | 36.0 | 35.8 | · | 66.1 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | 38.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.9 | 4.4 | · | 7.1 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 7.6% | 6.6% | · | 3.8% | 2.9% | 2.4% | · | 1.8% | 1.7% | 0.45% | · | -3.6% | -5.7% | -9.4% | · | -16.9% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Umsatz | $510M | — | — | $426M | — |
| Bruttogewinnmarge % | 57.4% | — | — | 51.5% | — |
| Betriebsgewinnmarge % | 37.5% | — | — | 32.6% | — |
| Nettoergebnis | $147M | — | — | $198M | — |
| Verwässerte EPS | $0.60 | — | — | $0.81 | — |
Bilanz
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | — | — | — | — |
| Liquiditätsgrad | 6.7 | — | — | 6.0 | — |
| Quick Ratio | 3.5 | — | — | 2.8 | — |
Cashflow
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | $28M | — | — | $110M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- ADMA Biologics (ADMA) erhält FDA-Erweiterung der Zulassung für ASCENIV
- Hier ist, was Analysten über ADMA Biologics (ADMA) denken
- Mizuho senkt PT für ADMA Biologics Inc. (ADMA) auf 24 USD von 30 USD
- ADMA Biologics (ADMA) könnte $200M Kapitalrückgabeprogramm einschließlich $125M ASR-Vereinbarung bekanntgeben
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 364 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 59 (-10 vs. Vorquartal) | 81 (+19 vs. Vorquartal) | 95 (-39 vs. Vorquartal) | 136 (+25 vs. Vorquartal) | +18.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| STATE STREET CORP | $143.261.104 | 17.116.022 | 11,67% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.568.881 | 10.103.809 | 6,89% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $84.440.661 | 10.088.490 | 6,88% | Aktien |
| Rubric Capital Management LP | $78.170.895 | 9.339.414 | 6,37% | Aktien |
| Capital Research Global Investors | $73.290.850 | 8.756.374 | 5,97% | Aktien |
| FIRST TRUST ADVISORS LP | $65.272.197 | 7.798.351 | 5,32% | Aktien |
| Caligan Partners LP | $47.918.309 | 5.725.007 | 3,90% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $43.542.717 | 5.201.126 | 3,55% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $28.505.265 | 3.405.647 | 2,32% | Aktien |
| B Group, Inc. | $27.307.477 | 3.262.542 | 2,22% | Aktien |
| Nuveen Asset Management, LLC | $22.724.385 | 1.325.037 | 1,85% | Aktien |
| GOLDMAN SACHS GROUP INC | $21.445.388 | 2.562.173 | 1,75% | Aktien |
| Nantahala Capital Management, LLC | $19.753.141 | 2.359.993 | 1,61% | Aktien |
| D. E. Shaw & Co., Inc. | $19.393.708 | 2.317.050 | 1,58% | Aktien |
| Ranger Investment Management, L.P. | $17.706.040 | 2.115.417 | 1,44% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.515.012 | 2.092.594 | 1,43% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $16.906.454 | 2.019.887 | 1,38% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $14.690.622 | 1.755.152 | 1,20% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $13.849.111 | 1.654.613 | 1,13% | Aktien |
| Fundsmith LLP | $13.806.256 | 1.649.493 | 1,12% | Aktien |
| Mesirow Institutional Investment Management, Inc. | $13.419.035 | 782.451 | 1,09% | Aktien |
| Life Cycle Investment Partners Ltd | $12.747.351 | 1.522.981 | 1,04% | Aktien |
| BANK OF AMERICA CORP /DE/ | $12.489.672 | 1.492.195 | 1,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $12.172.449 | 1.454.295 | 0,99% | Aktien |
| CITADEL ADVISORS LLC | $11.467.494 | 1.370.071 | 0,93% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $11.400.467 | 1.362.063 | 0,93% | Aktien |
| Clearline Capital LP | $11.171.648 | 1.334.725 | 0,91% | Aktien |
| Qube Research & Technologies Ltd | $11.019.674 | 1.316.568 | 0,90% | Aktien |
| National Philanthropic Trust | $10.006.302 | 1.195.496 | 0,82% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $9.848.828 | 1.176.682 | 0,80% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $9.660.888 | 1.154.228 | 0,79% | Aktien |
| Caption Management, LLC | $8.370.000 | 1.000.000 | 0,68% | Verkaufsoption |
| Stonepine Capital Management, LLC | $7.950.000 | 650.000 | 0,65% | Kaufoption |
| Public Sector Pension Investment Board | $6.664.370 | 796.221 | 0,54% | Aktien |
| ALGERT GLOBAL LLC | $6.505.072 | 777.189 | 0,53% | Aktien |
| Stonepine Capital Management, LLC | $6.193.800 | 740.000 | 0,50% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.749.537 | 686.922 | 0,47% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $5.582.790 | 667.000 | 0,45% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.461.676 | 652.530 | 0,44% | Aktien |
| ARDSLEY ADVISORY PARTNERS LP | $5.022.000 | 600.000 | 0,41% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $4.800.873 | 573.581 | 0,39% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $4.755.282 | 568.134 | 0,39% | Aktien |
| Caption Management, LLC | $4.603.500 | 550.000 | 0,37% | Kaufoption |
| RHUMBLINE ADVISERS | $4.485.141 | 535.862 | 0,37% | Aktien |
| MORGAN STANLEY | $4.475.046 | 534.653 | 0,36% | Aktien |
| MARATHON CAPITAL MANAGEMENT | $4.455.795 | 532.353 | 0,36% | Aktien |
| JANE STREET GROUP, LLC | $4.363.582 | 521.336 | 0,36% | Aktien |
| Caption Management, LLC | $3.933.900 | 470.000 | 0,32% | Aktien |
| CITIGROUP INC | $3.932.084 | 469.783 | 0,32% | Aktien |
| Swiss National Bank | $3.707.073 | 442.900 | 0,30% | Aktien |
| Ruffer LLP | $3.536.005 | 422.958 | 0,29% | Aktien |
| AMERIPRISE FINANCIAL INC | $3.495.939 | 417.675 | 0,28% | Aktien |
| Point72 Asset Management, L.P. | $3.464.636 | 413.935 | 0,28% | Aktien |
| Bridgewater Associates, LP | $3.356.864 | 401.059 | 0,27% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.303.639 | 394.700 | 0,27% | Kaufoption |
| ASHFORD CAPITAL MANAGEMENT INC | $3.257.115 | 361.500 | 0,27% | Aktien |
| FMR LLC | $3.249.586 | 388.242 | 0,26% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.101.085 | 370.500 | 0,25% | Verkaufsoption |
| Squarepoint Ops LLC | $2.992.300 | 357.503 | 0,24% | Aktien |
| Legal & General Group Plc | $2.970.780 | 354.932 | 0,24% | Aktien |
| Quantinno Capital Management LP | $2.767.800 | 330.681 | 0,23% | Aktien |
| BlackRock, Inc. | $2.716.216 | 324.518 | 0,22% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.683.926 | 297.883 | 0,22% | Aktien |
| Corient Private Wealth LP | $2.667.295 | 318.673 | 0,22% | Aktien |
| MARSHALL WACE, LLP | $2.571.717 | 307.254 | 0,21% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.514.907 | 279.124 | 0,20% | Aktien |
| Caligan Partners LP | $2.511.000 | 300.000 | 0,20% | Kaufoption |
| STATE OF WISCONSIN INVESTMENT BOARD | $2.370.417 | 283.204 | 0,19% | Aktien |
| PFG Investments, LLC | $2.261.390 | 270.178 | 0,18% | Aktien |
| Velan Capital Investment Management LP | $2.092.500 | 250.000 | 0,17% | Aktien |
| Future Fund LLC | $2.080.146 | 248.524 | 0,17% | Aktien |
| H D Vest Advisory Services | $2.024.515 | 111.176 | 0,16% | Aktien |
| PRUDENTIAL FINANCIAL INC | $2.007.168 | 239.805 | 0,16% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $1.895.961 | 226.518 | 0,15% | Aktien |
| Campbell & CO Investment Adviser LLC | $1.875.215 | 224.040 | 0,15% | Aktien |
| WOLVERINE TRADING, LLC | $1.821.330 | 123.900 | 0,15% | Kaufoption |
| Rafferty Asset Management, LLC | $1.807.887 | 215.996 | 0,15% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.724.379 | 206.019 | 0,14% | Aktien |
| DIADEMA PARTNERS LP | $1.674.000 | 200.000 | 0,14% | Kaufoption |
| Mariner, LLC | $1.496.157 | 178.752 | 0,12% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $1.357.731 | 74.437 | 0,11% | Aktien |
| LPL Financial LLC | $1.336.311 | 159.655 | 0,11% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $1.260.355 | 150.580 | 0,10% | Aktien |
| WOLVERINE TRADING, LLC | $1.211.280 | 82.400 | 0,10% | Verkaufsoption |
| Virtus Investment Advisers, LLC | $1.185.544 | 141.642 | 0,10% | Aktien |
| XTX Topco Ltd | $1.182.756 | 141.309 | 0,10% | Aktien |
| UBS Group AG | $1.127.774 | 134.740 | 0,09% | Aktien |
| MetLife Investment Management, LLC | $1.125.732 | 134.496 | 0,09% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $1.098.563 | 131.250 | 0,09% | Aktien |
| Nuveen, LLC | $1.078.901 | 128.901 | 0,09% | Aktien |
| Cetera Investment Advisers | $1.073.310 | 128.233 | 0,09% | Aktien |
| VANGUARD GROUP INC | $1.065.526 | 58.417 | 0,09% | Aktien |
| CreativeOne Wealth, LLC | $1.062.371 | 126.926 | 0,09% | Aktien |
| CITADEL ADVISORS LLC | $1.057.131 | 126.300 | 0,09% | Kaufoption |
| Odyssean, LLC | $1.042.048 | 124.498 | 0,08% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.041.086 | 124.383 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $1.037.043 | 123.900 | 0,08% | Verkaufsoption |
| Illinois Municipal Retirement Fund | $988.991 | 118.159 | 0,08% | Aktien |
| PROFUND ADVISORS LLC | $988.581 | 118.110 | 0,08% | Aktien |
| PERCEPTIVE ADVISORS LLC | $952.213 | 113.765 | 0,08% | Aktien |
Unternehmensinsider 20 Insider · 8 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Adam S Grossman | President and CEO | 16. März 2026 M | 2.112.777 | 0 | 12 | $-2.082.360 |
| Terry Kohler | CFO and Treasurer | 16. Juli 2026 A | 143.149 | 0 | 0 | $0 |
| Brad L. Tade | CFO and Treasurer | 19. Februar 2026 F | 232.940 | 0 | 0 | $0 |
| Brian Lenz | EVP, CFO | 7. März 2024 F | 703.002 | 0 | 0 | $0 |
| Kirk M Warshaw | CFO, Secretary | 13. Februar 2012 D | 5.208 | 0 | 0 | $0 |
| Arnold P Kling | President | 13. Februar 2012 D | 8.485 | 0 | 0 | $0 |
| Kaitlin M. Kestenberg-Messina | COO and SVP, Compliance | 24. Juli 2026 F | 443.061 | 0 | 1 | $-157.800 |
| James Mond | EVP, CSO and CMO | 25. Februar 2021 A | 137.535 | 0 | 0 | $0 |
| Jerrold B Grossman | Direktor | 27. Mai 2026 P | 520.284 | 3 | 0 | $250.874 |
| Lawrence P. Guiheen | Direktor | 13. März 2026 M | 30.000 | 0 | 0 | $0 |
| Steve Elms | Direktor | 6. März 2026 P | 2.045.730 | 2 | 0 | $217.420 |
| Eduardo Rene Salas | Direktor | 9. Februar 2026 A | 21.579 | 0 | 0 | $0 |
| Young Kwon | Direktor | 9. Februar 2026 A | 263.020 | 0 | 0 | $0 |
| Alison Cecily Finger | Direktor | 9. Februar 2026 A | 45.619 | 0 | 0 | $0 |
| Bryant Fong | Direktor | 26. Februar 2024 A | 83.941 | 0 | 0 | $0 |
| Martha J Demski | Direktor | 6. März 2023 A | 56.601 | 0 | 0 | $0 |
| Eric I Richman | Direktor | 28. Februar 2020 A | 44.030 | 0 | 0 | $0 |
| GOLDSTEIN DOV A MD | Direktor | 28. Februar 2020 A | 7.500 | 0 | 0 | $0 |
| Biotest Divestiture Trust | 10%-Eigentümer | 6. Juni 2019 S | 4.295.580 | 0 | 0 | $0 |
| R & R INVESTMENTS VI LLC | 10%-Eigentümer | 13. Februar 2012 D | 39.340 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 9 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Caligan Partners LP, David Johnson ×2 Einreichungen | 9. Dezember 2022 | — | Erste Einreichung | Passive Anlage | SEC |
| The Biotest Divestiture Trust, Eric Rosenbach ×2 Einreichungen | 7. Juni 2019 | — | Erste Einreichung | — | SEC |
| Biotest AG ×3 Einreichungen | 3. August 2018 | — | Erste Einreichung | — | SEC |
| Biotest Pharmaceuticals Corporation | 21. Mai 2018 | — | Erste Einreichung | — | SEC |
| OR ×8 Einreichungen | 16. November 2017 | — | Erste Einreichung | — | SEC |
| Biomark Capital Fund IV LP (the “Fund”), Biomark Capital Fund IV GP LLC (the “General Partner”), David S. Wetherell (“Wetherell”) | 30. Januar 2017 | — | Erste Einreichung | — | SEC |
| Burrill Capital Fund IV, L.P. (the “Fund”), Burrill & Company (BCF IV GP), LLC (the “General Partner”), G. Steven Burrill (“Burrill”), Bryant Fong (“Fong”), Victor Hebert (“Hebert”), Douglas Lind (“Lind”), David Wetherell (“Wetherell”), Joshua Zelig (“Zelig”) ×2 Einreichungen | 28. Oktober 2013 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 15. September 2006 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 8. September 2006 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 63 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| TMFS · RBB Fund, Inc. | 1,30% | 96.557 NS | 31. Mai 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,16% | 201.155 SH | 8. August 2026 | Täglich |
| BBP · ETFis Series Trust I | 0,83% | 47.844 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,56% | 281.674 NS | 30. April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,32% | 109.641 NS | 31. Mai 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 0,28% | 38.671 SH | 8. August 2026 | Täglich |
| IJT · iShares Trust | 0,26% | 2.149.439 SH | 8. August 2026 | Täglich |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,21% | 275.878 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,17% | 1.652.272 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,16% | 12.612 SH | 8. August 2026 | Täglich |
| XJR · iShares Trust | 0,15% | 27.488 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,14% | 2.077.912 SH | 8. August 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 35.750 SH | 8. August 2026 | Täglich |
| IJR · iShares Trust | 0,13% | 14.148.426 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 90.151 NS | 30. April 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,12% | 32.818 NS | 31. Mai 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 247.366 SH | 8. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,10% | 8.106 NS | 30. April 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 807.920 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,10% | 8.805 NS | 31. Mai 2026 | N-PORT |
| SAA · ProShares Trust | 0,08% | 2.846 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 5.870.129 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,07% | 70.846 SH | 8. August 2026 | Täglich |
| SMDX · Tidal Trust III | 0,07% | 8.104 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,07% | 81.574 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 1.327.333 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,06% | 791.152 NS | 30. April 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 31.008 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,05% | 10.910 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 150.270 NS | 31. Mai 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,04% | 449 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 1.140.912 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 109.138 NS | 30. April 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,04% | 77.725 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,04% | 10.075 SH | 8. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,03% | 1.448.225 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 664.197 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,03% | 8.533 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 14.368 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.659.600 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,02% | 8.634 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 31.610 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,01% | 2.517.984 SH | 8. August 2026 | Täglich |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,01% | 128 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 9.059 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 217 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 63.237 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 7.854 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 151.191 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 37.593 NS | 30. April 2026 | N-PORT |